People with history of polyps often do not get follow-up colonoscopy after a positive FIT test, and early-onset cancers are rising in Corn Belt states.

by Eric Fitzsimmons

COVID vaccines may improve immunotherapy effects, and a drug combination reduces the risk for death in bladder cancer.

by Darlene Dobkowski

Prior authorizations pose a significant time burden for patients, and sentinel lymph node biopsy reduces side effects in cervical cancer.

by Marci A. Landsmann

Older people with multiple myeloma can receive a less toxic drug regimen, and the FDA approves an immunotherapy for people with high-risk skin cancer.

by Thomas Celona

Widespread uptake of HPV vaccine linked to reduced rates of cancer-causing infection in all, and radiation prevents recurrence in locally advanced bladder cancer.

by Eric Fitzsimmons

US trial to look at impact of AI-assisted mammograms, and vitamin B12 may help curb chemotherapy-associated hand-foot syndrome.

by Darlene Dobkowski

Report highlights progress against cancer amid call for federal government to fund cancer research, and low-dose aspirin fends off recurrence after surgery in colorectal cancer.

by Marci A. Landsmann

Combination of targeted therapy and chemotherapy prolongs survival in lung cancer, and FDA approves a chemotherapy-releasing device to treat bladder cancer.

by Thomas Celona

Rising prostate cancer rates reignite questions about screening guidelines, and a government report describing the health risks of alcohol may never be published.

by Eric Fitzsimmons

Some people’s cancer treatment may not align with their care goals, and a blood test may detect ovarian cancer at early stages.

by Darlene Dobkowski